Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 127


Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor Vasculature.

Gilles ME, Maione F, Cossutta M, Carpentier G, Caruana L, Di Maria S, Houppe C, Destouches D, Shchors K, Prochasson C, Mongelard F, Lamba S, Bardelli A, Bouvet P, Couvelard A, Courty J, Giraudo E, Cascone I.

Cancer Res. 2016 Dec 15;76(24):7181-7193. Epub 2016 Oct 17.


Nucleolin Promotes Heat Shock-Associated Translation of VEGF-D to Promote Tumor Lymphangiogenesis.

Morfoisse F, Tatin F, Hantelys F, Adoue A, Helfer AC, Cassant-Sourdy S, Pujol F, Gomez-Brouchet A, Ligat L, Lopez F, Pyronnet S, Courty J, Guillermet-Guibert J, Marzi S, Schneider RJ, Prats AC, Garmy-Susini BH.

Cancer Res. 2016 Aug 1;76(15):4394-405. doi: 10.1158/0008-5472.CAN-15-3140. Epub 2016 Jun 8.


Implication of NPM1 phosphorylation and preclinical evaluation of the nucleoprotein antagonist N6L in prostate cancer.

Destouches D, Sader M, Terry S, Marchand C, Maillé P, Soyeux P, Carpentier G, Semprez F, Céraline J, Allory Y, Courty J, De La Taille A, Vacherot F.

Oncotarget. 2016 Oct 25;7(43):69397-69411. doi: 10.18632/oncotarget.8043.


Mutation-Independent Activation of the Anaplastic Lymphoma Kinase in Neuroblastoma.

Regairaz M, Munier F, Sartelet H, Castaing M, Marty V, Renauleaud C, Doux C, Delbé J, Courty J, Fabre M, Ohta S, Vielh P, Michiels S, Valteau-Couanet D, Vassal G.

Am J Pathol. 2016 Feb;186(2):435-45. doi: 10.1016/j.ajpath.2015.10.016. Epub 2015 Dec 12.


Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor model.

Benedetti E, Antonosante A, d'Angelo M, Cristiano L, Galzio R, Destouches D, Florio TM, Dhez AC, Astarita C, Cinque B, Fidoamore A, Rosati F, Cifone MG, Ippoliti R, Giordano A, Courty J, Cimini A.

Oncotarget. 2015 Dec 8;6(39):42091-104. doi: 10.18632/oncotarget.5990.


Pleiotrophin exerts its migration and invasion effect through the neuropilin-1 pathway.

Elahouel R, Blanc C, Carpentier G, Frechault S, Cascone I, Destouches D, Delbé J, Courty J, Hamma-Kourbali Y.

Neoplasia. 2015 Aug;17(8):613-24. doi: 10.1016/j.neo.2015.07.007.


Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery.

Kossatz S, Grandke J, Couleaud P, Latorre A, Aires A, Crosbie-Staunton K, Ludwig R, Dähring H, Ettelt V, Lazaro-Carrillo A, Calero M, Sader M, Courty J, Volkov Y, Prina-Mello A, Villanueva A, Somoza Á, Cortajarena AL, Miranda R, Hilger I.

Breast Cancer Res. 2015 May 13;17:66. doi: 10.1186/s13058-015-0576-1.


Excitation of tuberoinfundibular dopamine neurons by oxytocin: crosstalk in the control of lactation.

Briffaud V, Williams P, Courty J, Broberger C.

J Neurosci. 2015 Mar 11;35(10):4229-37. doi: 10.1523/JNEUROSCI.2633-14.2015.


Receptor protein tyrosine phosphatase beta/zeta is a functional binding partner for vascular endothelial growth factor.

Koutsioumpa M, Poimenidi E, Pantazaka E, Theodoropoulou C, Skoura A, Megalooikonomou V, Kieffer N, Courty J, Mizumoto S, Sugahara K, Papadimitriou E.

Mol Cancer. 2015 Feb 3;14:19. doi: 10.1186/s12943-015-0287-3.


Proliferation and migration activities of fibroblast growth factor-2 in endothelial cells are modulated by its direct interaction with heparin affin regulatory peptide.

Dos Santos C, Blanc C, Elahouel R, Prescott M, Carpentier G, Ori A, Courty J, Hamma-Kourbali Y, Fernig DG, Delbé J.

Biochimie. 2014 Dec;107 Pt B:350-7. doi: 10.1016/j.biochi.2014.10.002. Epub 2014 Oct 12.


Dynamic mesenchymal stem cells volumic seeding in a commercialized porous ceramic scaffold: a feasibility study.

Lemonnier S, Bouderlique T, Albanese P, Naili S, Chevallier N, Rouard H, Courty J, Lemaire T.

Comput Methods Biomech Biomed Engin. 2014;17 Suppl 1:4-5. doi: 10.1080/10255842.2014.931049. No abstract available.


Pleiotrophin commits human bone marrow mesenchymal stromal cells towards hypertrophy during chondrogenesis.

Bouderlique T, Henault E, Lebouvier A, Frescaline G, Bierling P, Rouard H, Courty J, Albanese P, Chevallier N.

PLoS One. 2014 Feb 7;9(2):e88287. doi: 10.1371/journal.pone.0088287. eCollection 2014.


Glycosaminoglycan mimetic associated to human mesenchymal stem cell-based scaffolds inhibit ectopic bone formation, but induce angiogenesis in vivo.

Frescaline G, Bouderlique T, Mansoor L, Carpentier G, Baroukh B, Sineriz F, Trouillas M, Saffar JL, Courty J, Lataillade JJ, Papy-Garcia D, Albanese P.

Tissue Eng Part A. 2013 Jul;19(13-14):1641-53. doi: 10.1089/ten.TEA.2012.0377.


Pleiotrophin promotes capillary-like sprouting from senescent aortic rings.

Besse S, Comte R, Fréchault S, Courty J, Joël de L, Delbé J.

Cytokine. 2013 Apr;62(1):44-7. doi: 10.1016/j.cyto.2013.02.002. Epub 2013 Mar 6.


Expression of the growth factor pleiotrophin and its receptor protein tyrosine phosphatase beta/zeta in the serum, cartilage and subchondral bone of patients with osteoarthritis.

Kaspiris A, Mikelis C, Heroult M, Khaldi L, Grivas TB, Kouvaras I, Dangas S, Vasiliadis E, Lioté F, Courty J, Papadimitriou E.

Joint Bone Spine. 2013 Jul;80(4):407-13. doi: 10.1016/j.jbspin.2012.10.024. Epub 2013 Jan 18.


The pseudopeptide HB-19 binds to cell surface nucleolin and inhibits angiogenesis.

Birmpas C, Briand JP, Courty J, Katsoris P.

Vasc Cell. 2012 Dec 24;4(1):21. doi: 10.1186/2045-824X-4-21.


Interplay between αvβ3 integrin and nucleolin regulates human endothelial and glioma cell migration.

Koutsioumpa M, Polytarchou C, Courty J, Zhang Y, Kieffer N, Mikelis C, Skandalis SS, Hellman U, Iliopoulos D, Papadimitriou E.

J Biol Chem. 2013 Jan 4;288(1):343-54. doi: 10.1074/jbc.M112.387076. Epub 2012 Nov 16.


Nucleolin mediates the antiangiogenesis effect of the pseudopeptide N6L.

Birmpas C, Briand JP, Courty J, Katsoris P.

BMC Cell Biol. 2012 Nov 13;13:32. doi: 10.1186/1471-2121-13-32.


Multivalent pseudopeptides targeting cell surface nucleoproteins inhibit cancer cell invasion through tissue inhibitor of metalloproteinases 3 (TIMP-3) release.

Destouches D, Huet E, Sader M, Frechault S, Carpentier G, Ayoul F, Briand JP, Menashi S, Courty J.

J Biol Chem. 2012 Dec 21;287(52):43685-93. doi: 10.1074/jbc.M112.380402. Epub 2012 Oct 29.


Loss of receptor protein tyrosine phosphatase β/ζ (RPTPβ/ζ) promotes prostate cancer metastasis.

Diamantopoulou Z, Kitsou P, Menashi S, Courty J, Katsoris P.

J Biol Chem. 2012 Nov 23;287(48):40339-49. doi: 10.1074/jbc.M112.405852. Epub 2012 Oct 11.

Supplemental Content

Loading ...
Support Center